The civilian mild hyperbaric oxygen therapy market is experiencing explosive growth as consumers embrace oxygen therapy for wellness, recovery, and performance optimization. According to Global Info Research, the global mild hyperbaric oxygen chamber market generated approximately US$173 million in revenue in 2025 and is projected to reach US$348 million by 2032, at a CAGR of 11.5%.

This civilian market surge is driven by several converging factors. First, there is growing recognition of oxygen therapy’s benefits beyond acute medical treatment. Consumers are discovering that regular mild hyperbaric oxygen sessions can improve sleep quality, accelerate post-exercise recovery, enhance cognitive function, and support healthy aging. Second, technological advancements have made chambers more accessible—modern units are quieter, more energy-efficient, and easier to operate than their predecessors. Third, the proliferation of wellness centers, boutique fitness studios, and longevity clinics has created new distribution channels and increased consumer awareness.
The commercial wellness sector represents a particularly significant opportunity. Luxury hotels, high-end fitness centers, corporate wellness programs, and medical spas are increasingly incorporating hyperbaric oxygen chambers as premium amenities. In Manchester, a new wellness studio has opened offering hyperbaric oxygen sessions alongside cryotherapy and red-light therapy. In Vietnam, an integrated wellness centre at a luxury resort now offers mild hyperbaric oxygen therapy as part of its medical wellness solutions. MD Hyperbaric has built a franchise platform around HBOT, bringing clinical-grade therapy into accessible, scalable formats outside traditional hospital settings.
The civilian market also benefits from the rise of “longevity medicine” and proactive health optimization. Contemporary studies confirm that hyperbaric chamber use can slow natural aging processes and counteract neurodegenerative changes. Consumers are increasingly viewing oxygen therapy not as a treatment for illness but as an investment in long-term health and vitality.
For manufacturers, the civilian market demands products that prioritize user experience alongside clinical efficacy. Key features include intuitive interfaces, quiet operation, aesthetic design, remote monitoring capabilities, and comprehensive safety systems. Digital integration—such as session logging and telehealth-enabled supervision—enhances user engagement and creates new pathways for evidence generation through real-world data.
